Key result
AF or flutter in suspected ACS links to ~37% fewer type 1 MIs requiring TLR.
Why the study?
AF and AFLUT are common in suspected ACS presentations and complicate the identification of type 1 MI, prompting the identification of predictors of type 1 MI requiring TLR.
Does the presence of AF/AFLUT predict the likelihood of type 1 MI requiring TLR in patients presenting with suspected ACS?
Observational (n=4,790)
Yes
Does the presence of AF/AFLUT predict the likelihood of type 1 MI requiring TLR in patients presenting with suspected ACS?
Patients with suspected ACS and concurrent AF/AFLUT are less likely to have a type 1 MI requiring revascularization, highlighting the diagnostic challenge and potential for unnecessary angiography in this population.
AF/AFLUT in suspected ACS may signal diagnostic challenges and unnecessary angiography; leaves open prospective validation of adjusted criteria.
Background Atrial fibrillation (AF) and atrial flutter (AFLUT) are common in patients presenting to the emergency department (ED) with suspected acute coronary syndrome (ACS) and severely complicate the identification of patients with type 1 myocardial infarction (MI). Purpose To identify predictors of type 1 MI requiring target lesion revascularization (TLR) in patients with AF/AFLUT undergoing coronary angiography (CA) because of suspected ACS. Methods Between 1/2014 and 11/2021 we retrospectively identified patients who underwent CA due to suspected ACS at two tertiary centers in Munich, Germany. Inclusion criterion was presence of raw-data ECG-recording. Patients with ST-elevation MI (STEMI) were excluded. AF/AFLUT was automatically identified and manually verified. The primary endpoint of the study was type 1 MI requiring TLR. The secondary endpoint was intrahospital mortality. The association between risk-identifiers and TLR was tested using multivariable logistic-regression analysis. Following subgroups were considered: angina pectoris, age ≥ 70 years, all cardiovascular (CV) risk factors, left-ventricular ejection fraction (LVEF) < 30% high sensitivity Troponin (hsT) >0.052 ng/ml and ischemic ECG changes. The interaction between subgroups and AF/AFLUT for identifying patients with type 1 MI was estimated by including the product of the subgroup identifier with AF/AFLUT in the multivariable model. Results We identified 4,790 patients (age 73; IQR 62-80 years, 1,451 females; 30.3%, Table 1) with available ECG recordings, who underwent diagnostic CA due to suspected ACS. In 3,126 (65.3%) cases a type 1 MI in need of TLR was identified. Patients with AF/AFLUT received TLR significantly less often than patients without AF/AFLUT (59.5 vs. 66.3%, p<0.001), which remained significant after adjustment for angina, age, kidney failure, arterial hypertension and sex (OR 0.63, 95%CI 0.53 – 0.75, p<0.001). After adjustment for the same factors, patients with AF/AFLUT did not suffer from higher mortality (OR 1.13 95%CI 0.77-1.64, p=0.533). There was no significant interaction between subgroups and AF/AFLUT for prediction of type 1 MI requiring TLR (Figure). Conclusion AF/AFLUT more commonly leads to unnecessary CA in patients presenting to the ED with suspected ACS. Angina pectoris, male sex, age ≥ 70 years and presence of CV risk factors are the most important predictors of type 1 MI requiring TLR in both patients with and without AF/AFLUT undergoing CA because of suspected ACS.
No takes yet. Share an insight, caveat, or question.
Sams et al. (2025) conducted an observational in Suspected acute coronary syndrome (n=4,790). Atrial fibrillation and atrial flutter (AF/AFLUT) vs. No AF/AFLUT was evaluated on Type 1 MI requiring target lesion revascularization (TLR) (OR 0.63, 95% CI 0.53-0.75, p=<0.001). Atrial fibrillation or flutter in suspected ACS was associated with a lower likelihood of type 1 MI requiring TLR compared to those without (OR 0.63; 95% CI 0.53-0.75; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: